RxDoctor Payments Data

Jeffrey Milks, MD

Family Medicine · New Albany, OHNPI 1114903721

Payments from drug & device makers

$692in general payments, 2019–2025

Across 28 payments — averaging $24.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$140
  • Amgen$112
  • AbbVie$78
  • Takeda Pharmaceuticals U.S.A., Inc.$68
  • Astellas Pharma US Inc$35
  • Pfizer$33
  • plus $226 from 12 others

What the payments were for

  • Food & beverage$692100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$692 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$69,743
Medicare patients
76
Services billed
13,617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$57,158
EliquisApixaban29$27,948
MounjaroTirzepatide13$13,681
Repatha SureclickEvolocumab11$9,180
Oxycodone Hcl33$929
Rosuvastatin Calcium70$756
Levothyroxine Sodium52$736
Atorvastatin Calcium52$702
SynthroidLevothyroxine Sodium12$696
Diltiazem 24hr Er (La)Diltiazem Hcl12$694
Albuterol Sulfate HfaAlbuterol Sulfate26$619
Zolpidem Tartrate57$590
ValacyclovirValacyclovir Hcl15$552
Testosterone Cypionate11$526
Lorazepam26$513

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$29$57,15836 claims
PfizerEliquis$33$27,94829 claims
Lilly USA, LLCMounjaro$19$13,68113 claims
AbbVieSynthroid$78$69612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in New Albany

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →